Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Use of cell permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various cancer diseases

No-Receipt date 2015-00637 - 02/03/2015
No-Filing date 20150400466 - 02/03/2015
No-Granting date 3085583 - 13/03/2015
No-EPO application date 13002793.1 - 02/06/2009
No-EPO granting date 2650008 - 17/12/2014
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 3/2015 - 21/04/2015
Expiration date 03/06/2029
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities WOEP2008/00434130/05/2008/WO
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 38/01
A61K 38/03
A61K 38/04
A61P 11/00
A61P 17/00
A61P 25/00
A61P 31/12
A61P 37/00
A61P 9/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
580985 XIGEN INFLAMMATION LTD. ARCH. MAKARIOU III 195 NEOCLEOUS HOUSE3030 LIMASSOL CYPRUS

Inventors
CodeFirstnameSurname
1404256 BONNY, CHRISTOPHE

Representatives
CodeFirstnameSurnameAddressTownZip
3178STEFANOS ALEXIOSTSIMIKALIS "TSIMIKALIS KALONAROU DIKIGORIKI ETAIREIA"NEOFYTOU VAMVA 1ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
8126STEFANOS ALEXIOSTSIMIKALISNEOFYTOU VAMVA 1ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments
DateOperationDescreption
1/11/2018 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 12/2017 Αρ. Πρωτ. Γ.Δ. 50/11.01.2018

Payments history 8 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015